Cancer trials suspended for new patients
Beth Israel Deaconess Medical Center temporarily closed all its cancer trials to new patients last week, after audits found that several researchers had not properly submitted patient data to the committee that oversees oncology research and to trial sponsors.
“Some of our clinical trials were not running with the high standards that we expect,’’ Randy Mason, vice president of research operations, wrote in an e-mail to hospital executives and physician leaders last week.
He described the lapses as involving documentation and reporting compliance and said the hospital has not found any “issues of patient harm.’’
- 5 Hot Healthcare Ideas from SXSW
- Hospital CEO Turnover Hits Record High
- Hospital Groups Strike Back at Hospital Rating Systems
- Another SGR Patch Likely, Lawmaker Says
- 4 Marketing Tactics for Hospitals on Instagram
- Rules to Rein in HIX Narrow Networks Could Drive Away Payers
- EHR Spending Continues, But Jury Still Out on ROI
- Care Coordination a Cost-Cutting Quality Driver
- The Secret to Physician Engagement? It's Not Better Pay
- Lahey Health Reexamines the Appropriate Care Model